Encompass Health makes investment in Medalogix
BIRMINGHAM, Ala., June 24, 2019 /PRNewswire/ -- Encompass Health Corp. (EHC), a leader in integrated healthcare services, today announced it has made a minority equity investment in Medalogix, a leader in predictive analytics and data science for home health and hospice.
Medalogix is assisting Encompass Health in preparing for the impending changes to the Patient-Driven Groupings Model, a new home health payment model for Medicare patients expected to take effect Jan. 1, 2020.
"Our investment in Medalogix underscores our excitement for working with an innovative, predictive analytics company that shares our standards and dedication to doing what's best for patients. Medalogix is helping us prepare for an array of value-based payment models," said Luke James, chief strategy officer at Encompass Health - Home Health & Hospice.
In 2016, Encompass Health and Medalogix entered into a co-development arrangement focused on the development of Medalogix Care, an analytical tool that provides evidence-based and patient-specific recommended care plans focused on improving patient outcomes. In addition to providing clinical decision support for the plan of care, the Medalogix Care recommendation provides a basis for inter-disciplinary collaboration and ongoing cross-functional case management throughout the episode of care.
"Our core focus right now is helping our clients transition to PDGM. Our products, especially Medalogix Care, provide a playbook to manage resources in a way that is sustainable through this industry shift while focusing on what is right for each patient," said Elliott Wood, president and chief executive officer of Medalogix. "Leveraging Medalogix in a meaningful way requires the home health agency to have great leadership and a culture that can sustain transformation with technology. Encompass Health has consistently demonstrated an ability to execute on these types of transformational initiatives, and we are thrilled to enhance our relationship with Encompass Health and make a difference together in the industry."
Encompass Health was the first organization to adopt Medalogix Care, which helps to improve patient outcomes by developing an optimal care plan.
About Encompass Health
As a national
leader in integrated healthcare services, Encompass Health
(EHC) offers both facility-based and
home-based patient care through its network of inpatient
rehabilitation hospitals, home health agencies and hospice
agencies. With a national footprint that includes 131 hospitals,
221 home health locations, and 59 hospice locations in 37 states
and Puerto Rico, the Company is committed to
delivering high-quality, cost-effective, integrated care across the
healthcare continuum. Encompass Health is ranked as one of
Fortune's 100 Best Companies to Work For. For more information,
visit encompasshealth.com, or follow us on
our newsroom, Twitter and Facebook.
About Medalogix
Medalogix was founded in 2012 with the desire to help home health
agencies identify patients on census at-risk for unplanned
rehospitalization. Since that time, Medalogix has developed
products and services which help home health providers create
clinical programs, manage large populations more efficiently, and
drive value to strategic partnerships. Medalogix products have
been recognized by Harvard Business Review, HIMSS, Fierce
Healthcare, and Becker's Hospital Review as innovative solutions
for improving America's healthcare system. For more
information, please visit Medalogix at http://medalogix.com/ or follow on
Twitter at: @Medalogix.
Forward-Looking Statements
Statements contained in this press release which are not
historical facts, such as the nature of the investment and
predictions regarding adapting to regulatory changes and
initiatives including PDGM and value-based payment models, are
forward-looking statements. In addition, Encompass Health, through
its senior management, may from time to time make forward-looking
public statements concerning the matters described herein. All such
estimates, projections, and forward-looking information speak only
as of the date hereof, and Encompass Health undertakes no duty to
publicly update or revise such forward-looking information, whether
as a result of new information, future events, or otherwise. Such
forward-looking statements are necessarily estimates based upon
current information and involve a number of risks and
uncertainties. Actual events or results may differ materially from
those anticipated in these forward-looking statements as a result
of a variety of factors. While it is impossible to identify all
such factors, factors which could cause actual events or results to
differ materially from those estimated by Encompass Health include,
but are not limited to, Medalogix's ability to develop and
implement data and analytic tools that provide value for home
health and hospice providers; Encompass Health's ability to comply
with extensive, complex, and ever-changing regulations in the
healthcare industry; any adverse outcome of various lawsuits,
claims, and legal or regulatory proceedings involving Encompass
Health, including its pending DOJ and HHS-OIG investigations and
any matters related to yet undiscovered issues, if any, at acquired
companies; potential disruptions, breaches, or other incidents
affecting the proper operation, availability, or security of
Encompass Health's, Medalogix's or other third-party's information
systems, including unauthorized access to or theft of patient,
business associate, or other sensitive information; changes, delays
in (including in connection with resolution of Medicare payment
reviews or appeals), or suspension of reimbursement for Encompass
Health's services by governmental or private payors; and other
factors which may be identified from time to time in Encompass
Health's SEC filings and other public announcements, including
Encompass Health's Form 10-K for the year ended Dec. 31,
2018 and Form 10-Q for the quarter ended March 31,
2019.
Media Contact:
Hillary
Carnel | 205-970-5912
[email protected]
Investor Relations Contact:
Crissy Carlisle | 205-970-5860
[email protected]
View original content to download multimedia:http://www.prnewswire.com/news-releases/encompass-health-makes-investment-in-medalogix-300873753.html